Allogeneic transplantation, Fas signaling, and dysregulation of hepcidin.

[1]  A. Buser,et al.  Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  Philip D. Zisman,et al.  Cellular FLICE-like inhibitory protein deviates myofibroblast fas-induced apoptosis toward proliferation during lung fibrosis. , 2012, American journal of respiratory cell and molecular biology.

[3]  A. Safa,et al.  c-FLIP, a master anti-apoptotic regulator. , 2012, Experimental oncology.

[4]  Liying Wang,et al.  Antioxidant c-FLIP Inhibits Fas Ligand-Induced NF-κB Activation in a Phosphatidylinositol 3-Kinase/Akt-Dependent Manner , 2011, The Journal of Immunology.

[5]  Thomas B. Sundberg,et al.  Manipulating the Bioenergetics of Alloreactive T Cells Causes Their Selective Apoptosis and Arrests Graft-Versus-Host Disease , 2011, Science Translational Medicine.

[6]  H. Deeg,et al.  The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes. , 2010, Blood.

[7]  A. Marx,et al.  A single nucleotide polymorphism determines protein isoform production of the human c-FLIP protein. , 2009, Blood.

[8]  H. Deeg,et al.  Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice. , 2009, Blood.

[9]  H. Deeg,et al.  Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  Yigong Shi,et al.  FLIP and the death effector domain family , 2008, Oncogene.

[11]  M. Wernli,et al.  Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated apoptosis , 2008, Oncogene.

[12]  H. Deeg,et al.  Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2 , 2008, Apoptosis.

[13]  Jerry Kaplan,et al.  Regulation of iron acquisition and storage: consequences for iron-linked disorders , 2008, Nature Reviews Molecular Cell Biology.

[14]  T. Tsuruo,et al.  Impairment of the ubiquitin‐proteasome system by cellular FLIP , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[15]  P. Armand,et al.  Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. , 2007, Blood.

[16]  G. Ramadori,et al.  Changes of gene expression of iron regulatory proteins during turpentine oil-induced acute-phase response in the rat , 2007, Laboratory Investigation.

[17]  Christian Trautwein,et al.  STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. , 2007, Gastroenterology.

[18]  P. Krammer,et al.  The c-FLIP–NH2 terminus (p22-FLIP) induces NF-κB activation , 2006, The Journal of experimental medicine.

[19]  H. Deeg,et al.  The clinical spectrum of acute graft-versus-host disease. , 2006, Seminars in hematology.

[20]  A. Donovan,et al.  Comparative studies of duodenal and macrophage ferroportin proteins. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[21]  H. Deeg,et al.  Protection of human and murine hepatocytes against Fas-induced death by transferrin and iron , 2006, Apoptosis.

[22]  M. Peter,et al.  A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes. , 2005, Carcinogenesis.

[23]  E. Hurt,et al.  The role of IL-6 and STAT3 in inflammation and cancer. , 2005, European journal of cancer.

[24]  J. Tschopp,et al.  Cellular FLIP (Long Form) Regulates CD8+ T Cell Activation through Caspase-8-Dependent NF-κB Activation1 , 2005, The Journal of Immunology.

[25]  M. Manns,et al.  The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. , 2005, The Journal of clinical investigation.

[26]  M. Peter.  The flip side of FLIP. , 2004, The Biochemical journal.

[27]  E. Holler,et al.  Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[28]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[29]  J. Tschopp,et al.  N-Terminal Fragment of c-FLIP(L) Processed by Caspase 8 Specifically Interacts with TRAF2 and Induces Activation of the NF-κB Signaling Pathway , 2004, Molecular and Cellular Biology.

[30]  H. Deeg,et al.  Prevention of Fas-mediated hepatic failure by transferrin , 2004, Laboratory Investigation.

[31]  Wan-Ni Yu,et al.  Phosphatidylinositide 3-Kinase Priming Couples c-FLIP to T Cell Activation* , 2004, Journal of Biological Chemistry.

[32]  R. Taub.  Hepatoprotection via the IL-6/Stat3 pathway. , 2003, The Journal of clinical investigation.

[33]  C. Miao,et al.  High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors. , 2003, Human gene therapy.

[34]  K. Shiraki,et al.  Cellular FLICE/Caspase-8–Inhibitory Protein as a Principal Regulator of Cell Death and Survival in Human Hepatocellular Carcinoma , 2003, Laboratory Investigation.

[35]  J. Tschopp,et al.  The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex* , 2002, The Journal of Biological Chemistry.

[36]  Masaharu Akiyama,et al.  Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications , 2002, Oncogene.

[37]  N. Mounier,et al.  CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications. , 2002, Blood.

[38]  J. Maher,et al.  Anti-Fas Induces Hepatic Chemokines and Promotes Inflammation by an NF-κB-independent, Caspase-3-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[39]  Margot Thome,et al.  Regulation of lymphocyte proliferation and death by flip , 2001, Nature Reviews Immunology.

[40]  G. Ciliberto,et al.  Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xL* , 2001, The Journal of Biological Chemistry.

[41]  D. Brenner,et al.  NF-κB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α– and Fas-mediated apoptosis , 2001 .

[42]  F. Martinon,et al.  The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways , 2000, Current Biology.

[43]  K. Matsushima,et al.  Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. , 1999, The Journal of clinical investigation.

[44]  S. Nagata,et al.  Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease. , 1999, International immunology.

[45]  Margot Thome,et al.  Inhibition of death receptor signals by cellular FLIP , 1997, Nature.

[46]  I. Stamenkovic,et al.  The CD95 (APO-1/Fas) Receptor Activates NF-B Independently of Its Cytotoxic Function (*) , 1996, The Journal of Biological Chemistry.

[47]  S. Weitzman,et al.  Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity. , 1995, Free radical biology & medicine.

[48]  T. Libermann,et al.  Activation of interleukin-6 gene expression through the NF-kappa B transcription factor , 1990, Molecular and cellular biology.